Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Acq. announced
Consulting agrmnt
CC transcript
Filed Chapter 11
Appointed director
Asset disposition
Credit agrmnt [a]

IMPLANT SCIENCES CORP (IMSC) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/01/2017 8-K Filed for Chapter 11
07/10/2017 8-K Quarterly results
05/25/2017 8-K Form 8-K - Current report
05/19/2017 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Secure Point Technologies, Inc. Responds to Zapata Industries Baseless and False Allegations"
01/13/2017 8-K Form 8-K - Current report
01/06/2017 8-K Form 8-K - Current report
12/01/2016 8-K Form 8-K - Current report
11/14/2016 8-K Form 8-K - Current report
11/04/2016 8-K Acquisition/merger/asset purchase announced
Docs: "Amendment No. 1 to Asset Purchase Agreement, by and among Implant Sciences Corporation, C Acquisition Corp., Accurel Systems International Corporation, IMX Acquisition Corp. and L-3 Communications Corporation",
"Amendment No. 2 to Asset Purchase Agreement, by and among Implant Sciences Corporation, C Acquisition Corp., Accurel Systems International Corporation, IMX Acquisition Corp. and L-3 Communications Corporation",
"First Amendment to Senior Secured, Super-Priority Debtor-in-Possession Loan and Security Agreement, by and among Implant Sciences Corporation, C Acquisition Corp., Accurel Systems International Corporation, IMX Acquisition Corp. and DIP SPV I, L.P"
10/14/2016 8-K Acquisition/merger/asset purchase announced
Docs: "Asset Purchase Agreement, by and among Implant Sciences Corporation, C Acquisition Corp., Accurel Systems International Corporation, IMX Acquisition Corp. and L-3 Communications Corporation",
"Senior Secured, Super-Priority Debtor-in-Possession Loan and Security Agreement, by and among Implant Sciences Corporation, C Acquisition Corp., Accurel Systems International Corporation, IMX Acquisition Corp. and DIP SPV I, L.P",
"Implant Sciences Corporation Investor Relations"
10/11/2016 8-K Form 8-K - Current report
09/16/2016 8-K Form 8-K - Current report
08/10/2016 8-K Form 8-K - Current report
08/01/2016 8-K Form 8-K - Current report
07/22/2016 8-K Form 8-K - Current report
05/19/2016 8-K Form 8-K - Current report
04/08/2016 8-K Credit agreement amendment
Docs: "Articles of Amendment to the Restated Articles of Organization of Implant Sciences Corporation, adopted April 6, 2016",
"Consent and Second Omnibus Amendment to Secured Term Notes, and effective March 30, 2016, between Implant Sciences Corporation, the Guarantors named therein, certain Investors and BAM Administrative Services, LLC, as Agent",
"Omnibus Fourteenth Amendment to Credit Agreement and Sixteenth Amendment to Note and Warrant Purchase Agreement, and effective March 31, 2016, among Implant Sciences Corporation, the Guarantors named therein, DMRJ Group LLC and Montsant Partners LLC",
"Comfort Letter, dated effective March 31, 2016, between the Company, DMRJ Group LLC and Montsant Partners LLC",
"Press Release of Implant Sciences Corporation"
02/19/2016 8-K Quarterly results, Conference call transcript
Docs: "IMPLANT SCIENCES REPORTS SECOND QUARTER FISCAL 2016 FINANCIAL RESULTS Quarterly revenue increase 380.7% to $10.3 million Six months revenue increase 515.6% to $24.7 million",
"Implant Sciences Corporation conference call transcript held on February 11, 2016"
01/04/2016 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Accounts Receivable Purchase Agreement, between Implant Sciences Corporation and Republic Capital Access, LLC",
"Lien Release Agreement, between Republic Capital Access, LLC and DMRJ Group, LLC",
"Lien Release and Amendment Agreement, between Republic Capital Access, LLC, BAM Administrative Services, LLC and Implant Sciences Corporation"
11/18/2015 8-K Quarterly results, Conference call transcript
Docs: "IMSC_3PATENTS PR (EGS 5.8.15) (00359966).DOCX",
"Implant Sciences Corporation conference call transcript held on November 12, 2015"
10/02/2015 8-K Quarterly results, Conference call transcript
Docs: "IMPLANT SCIENCES REPORTS FOURTH QUARTER AND FISCAL 2015 FINANCIAL RESULTS",
"Implant Sciences Corporation conference call transcript held on September 28, 2015"
09/09/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Press Release of Implant Sciences Corporation"
07/07/2015 8-K Submission of Matters to a Vote of Security Holders
05/20/2015 8-K Quarterly results, Conference call transcript
Docs: "Implant Sciences Corporation Condensed Consolidated Balance Sheets",
"Implant Sciences Corporation conference call transcript held on May 14, 2015 at 4:15 PM ET"
04/29/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
04/09/2015 8-K Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
03/25/2015 8-K Credit agreement amendment
Docs: "Consent and Omnibus Amendment to Secured Term Notes, between Implant Sciences Corporation, certain Investors and BAM Administrative Services, LLC, as Agent",
"Omnibus Thirteenth Amendment to Credit Agreement and Fifteenth Amendment to Note and Warrant Purchase Agreement, between Implant Sciences Corporation and DMRJ Group LLC",
"Press Release of Implant Sciences Corporation"
03/04/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amended and Restated Change of Control Payment Plan"
02/20/2015 8-K Quarterly results, Conference call transcript
Docs: "IMPLANT SCIENCES REPORTS SECOND QUARTER FISCAL 2015 FINANCIAL RESULTS Wilmington, MA…February 17, 2015…Implant Sciences Corporation , a high technology supplier of systems and sensors for the homeland security market and related industries, today announced financial results for the three and six months ended December 31, 2014. Revenues for the three months ended December 31, 2014 decreased 32.0%, to $2.1 million, from $3.2 million for the comparable prior year period. Our net loss for the three months ended December 31, 2014 was $6.2 million as compared with a net loss of $4.4 million for the comparable prior year period, an increase of $1.8 million. Revenues for the six months ended December 31, 2014 decreased 7.1%, to $4.0 million, from $4.3 million for the comparable prior year period. ...",
"Implant Sciences Corporation conference call transcript held on February 17, 2015 at 4:15 PM ET"
02/09/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Implant Sciences Appoints Robert Liscouski as Executive Vice President"
01/23/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Separation Agreement and Release",
"Implant Sciences Board Announces Appointment of Dr. William McGann as CEO"
11/18/2014 8-K Quarterly results
Docs: "Press Release of Implant Sciences Corporation",
"IMPLANT SCIENCES REPORTS FIRST QUARTER FISCAL 2015 FINANCIAL RESULTS",
"Implant Sciences Corporation conference call script held on November 14, 2014 at 11:00 AM ET"
10/01/2014 8-K Quarterly results, Conference call transcript
Docs: "IMPLANT SCIENCES REPORTS FOURTH QUARTER AND FISCAL 2014 FINANCIAL RESULTS",
"Transcript of Implant Sciences Corporation conference call held on September 29, 2014 at 4:15 PM ET"
07/08/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Implant Sciences Corporation's 2014 Stock Option Plan"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy